Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.

The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.

The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.

Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.

For more information on Parkinson’s research please visit Parkinson’s Europe website.

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

6 world-class wildlife shots by a photographer with Parkinson’s

Wildlife photographer with Parkinson’s shares his favourite shots

Bill Bucklew on walking 2,500 miles for Parkinson’s

Bill Bucklew tells us why he's not afraid of failure

10 shocking facts that show what it’s like to be a carer

Highlighting the issues faced by carers throughout Europe

Could a sea sponge support the search for Parkinson’s disease treatments?

How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

6 world-class wildlife shots by a photographer with Parkinson’s

Interviews

Bill Bucklew on walking 2,500 miles for Parkinson’s

Carers' Corner

10 shocking facts that show what it’s like to be a carer

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

6 world-class wildlife shots by a photographer with Parkinson’s

Interviews

Bill Bucklew on walking 2,500 miles for Parkinson’s

Carers' Corner

10 shocking facts that show what it’s like to be a carer

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Sign in